Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Stadler, Walter M.

One or more keywords matched the following properties of Stadler, Walter M.

Property	Value
keywords	Renal Cancer
overview	Dr. Stadler is a clinical trialist focused on developing novel therapies and biomarkers, especially for genitourinary cancer. In addition to an extensive history performing trials in kidney, bladder, and prostate cancer, he also has broad experience in leading efforts supporting clinical trial infrastructure and conduct. These include renal cancer cadre leader for the Cancer and Leukemia Group B (CALGB, now Alliance), PI for a DOD funded prostate cancer clinical trials consortium, co-PI for a Prostate Cancer SPORE, PI for the NCI funded N01 contract for early phase clinical trials, and a current role as Dean for Clinical Research

Property

Value

keywords

Renal Cancer

overview

Dr. Stadler is a clinical trialist focused on developing novel therapies and biomarkers, especially for genitourinary cancer. In addition to an extensive history performing trials in kidney, bladder, and prostate cancer, he also has broad experience in leading efforts supporting clinical trial infrastructure and conduct. These include renal cancer cadre leader for the Cancer and Leukemia Group B (CALGB, now Alliance), PI for a DOD funded prostate cancer clinical trials consortium, co-PI for a Prostate Cancer SPORE, PI for the NCI funded N01 contract for early phase clinical trials, and a current role as Dean for Clinical Research

One or more keywords matched the following items that are connected to Stadler, Walter M.

Item Type	Name
Concept	Kidney Neoplasms
Academic Article	High-dose continuous intravenous infusion of interleukin-2 therapy for metastatic renal cell carcinoma: the University of Chicago experience.
Academic Article	Human renal cancer carcinogenesis: a review of recent advances.
Academic Article	Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer.
Academic Article	Serum interleukin-6 levels in metastatic renal cell cancer: correlation with survival but not an independent prognostic indicator.
Academic Article	A phase II study of subcutaneous recombinant human interleukin-4 in metastatic renal cell carcinoma.
Academic Article	Cytokine therapy in metastatic renal cancer.
Academic Article	Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.
Academic Article	Allogeneic peripheral blood stem cell transplantation for metastatic renal cell carcinoma.
Academic Article	Flavopiridol metabolism in cancer patients is associated with the occurrence of diarrhea.
Academic Article	Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.
Academic Article	Kidney cancer.
Academic Article	Multicenter phase II trial of interleukin-2, interferon-alpha, and 13-cis-retinoic acid in patients with metastatic renal-cell carcinoma.
Academic Article	Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results.
Academic Article	Flt-3 ligand and sequential FL/interleukin-2 in patients with metastatic renal carcinoma: clinical and biologic activity.
Academic Article	A phase II trial of intravenous gemcitabine and 5-fluorouracil with subcutaneous interleukin-2 and interferon-alpha in patients with metastatic renal cell carcinoma.
Academic Article	Renal cancer immunotherapy: a ray of hope or regression to the mean?
Academic Article	Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.
Academic Article	A phase II trial of weekly intravenous ranpirnase (Onconase), a novel ribonuclease in patients with metastatic kidney cancer.
Academic Article	Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
Academic Article	A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.
Academic Article	Acute bilateral abducens paralysis due to oxaliplatin.
Academic Article	Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma.
Academic Article	Phase II trial of PS-341 in patients with renal cell cancer: a University of Chicago phase II consortium study.
Academic Article	Gene expression profiling of renal medullary carcinoma: potential clinical relevance.
Academic Article	Randomized phase II study of multiple dose levels of CCI-779, a novel mammalian target of rapamycin kinase inhibitor, in patients with advanced refractory renal cell carcinoma.
Academic Article	Prognostic factors for survival with gemcitabine plus 5-fluorouracil based regimens for metastatic renal cancer.
Academic Article	Randomized discontinuation design: application to cytostatic antineoplastic agents.
Academic Article	Novel kinase inhibitors in renal cell carcinoma: progressive development of static agents.
Academic Article	Successful implementation of the randomized discontinuation trial design: an application to the study of the putative antiangiogenic agent carboxyaminoimidazole in renal cell carcinoma--CALGB 69901.
Academic Article	The role of systemic chemotherapy in the treatment of kidney cancer.
Academic Article	Cytotoxic chemotherapy for metastatic renal cell carcinoma.
Academic Article	Targeted agents for the treatment of advanced renal cell carcinoma.
Academic Article	Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Academic Article	Identification of deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling.
Academic Article	A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell carcinoma.
Academic Article	A University of Chicago consortium phase II trial of SB-715992 in advanced renal cell cancer.
Academic Article	Sorafenib in advanced clear-cell renal-cell carcinoma.
Academic Article	Chromosomes, hypoxia, angiogenesis, and trial design: a brief history of renal cancer drug development.
Academic Article	Multiple reference tissue method for contrast agent arterial input function estimation.
Academic Article	Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma.
Academic Article	Innovations and challenges in renal cancer: consensus statement from the first international conference.
Academic Article	Therapeutic options for variant renal cancer: a true orphan disease.
Academic Article	Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma.
Academic Article	Phase II trial of carboplatin and paclitaxel in papillary renal cell carcinoma.
Academic Article	Dynamic contrast-enhanced magnetic resonance imaging pharmacodynamic biomarker study of sorafenib in metastatic renal carcinoma.
Academic Article	Renal medullary-like carcinoma in an adult without sickle cell hemoglobinopathy.
Academic Article	Phase III trial of bevacizumab plus interferon alfa versus interferon alfa monotherapy in patients with metastatic renal cell carcinoma: final results of CALGB 90206.
Academic Article	Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma.
Academic Article	A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma.
Academic Article	Sorafenib for treatment of renal cell carcinoma: Final efficacy and safety results of the phase III treatment approaches in renal cancer global evaluation trial.
Academic Article	A phase II study of gemcitabine and capecitabine in metastatic renal cancer: a report of Cancer and Leukemia Group B protocol 90008.
Academic Article	New therapeutic options for renal cell carcinoma.
Academic Article	Sorafenib.
Academic Article	Combination therapy of imatinib mesylate and interferon-alpha demonstrates minimal activity and significant toxicity in metastatic renal cell carcinoma: results of a single- institution phase II trial.
Academic Article	Safety and efficacy results of the advanced renal cell carcinoma sorafenib expanded access program in North America.
Academic Article	A phase II study of ixabepilone (BMS-247550) in metastatic renal-cell carcinoma.
Academic Article	Gene expression profiling in kidney cancer: combining differential expression and chromosomal and pathway analyses.
Academic Article	Safety and efficacy of sorafenib in elderly patients treated in the North American advanced renal cell carcinoma sorafenib expanded access program.
Academic Article	Prognostic factors in localized renal cell cancer.
Academic Article	Bevacizumab and everolimus in renal cancer: a rational way forward.
Academic Article	A phase I study of sirolimus and bevacizumab in patients with advanced malignancies.
Academic Article	Antitumor activity and biomarker analysis of sunitinib in patients with bevacizumab-refractory metastatic renal cell carcinoma.
Academic Article	Bevacizumab plus interferon alfa compared with interferon alfa monotherapy in patients with metastatic renal cell carcinoma: CALGB 90206.
Academic Article	Effective therapy for metastatic renal cancer, whither to now.
Academic Article	A phase II trial of sequential chemotherapy with docetaxel and methotrexate followed by gemcitabine and cisplatin for metastatic urothelial cancer.
Academic Article	Resampling phase III data to assess phase II trial designs and endpoints.
Academic Article	A phase II study of the efficacy and safety of AMG 102 in patients with metastatic renal cell carcinoma.
Academic Article	Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma.
Academic Article	Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma.
Academic Article	Pazopanib in renal cell carcinoma.
Academic Article	Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer.
Academic Article	Multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma.
Academic Article	Granulocyte-macrophage-colony stimulating factor in combination immunotherapy for patients with metastatic renal cell carcinoma: results of two phase II clinical trials.
Academic Article	A high rate of venous thromboembolism in a multi-institutional phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil and daily thalidomide in patients with metastatic renal cell carcinoma.
Academic Article	A molecular classification of papillary renal cell carcinoma.
Academic Article	Activities and accomplishments of the cancer and leukemia group B genitourinary committee.
Academic Article	Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study.
Academic Article	A phase II study of depsipeptide in refractory metastatic renal cell cancer.
Academic Article	Angiogenesis inhibition in non-clear cell renal cancer.
Academic Article	Vascular endothelial growth factor pathway-targeted therapy as initial systemic treatment of patients with renal cancer.
Academic Article	A phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma.
Academic Article	Baseline patient-reported kidney cancer-specific symptoms as an indicator for median survival in sorafenib-refractory metastatic renal cell carcinoma.
Academic Article	Renal cancer therapeutics: now what?
Academic Article	Estimation of renal cell carcinoma treatment effects from disease progression modeling.
Academic Article	Axitinib in metastatic renal cell carcinoma: results of a pharmacokinetic and pharmacodynamic analysis.
Academic Article	Progression-free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma.
Academic Article	Predictive markers in advanced renal cell carcinoma.
Academic Article	Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Academic Article	A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.
Academic Article	Maturing of renal cancer therapeutics.
Academic Article	FDG-PET as a predictive biomarker for therapy with everolimus in metastatic renal cell cancer.
Academic Article	Optimal use of imaging to guide treatment decisions for kidney cancer.
Academic Article	Progression-free survival: does a correlation with survival justify its role as a surrogate clinical endpoint?
Academic Article	First-in-human multicenter phase I study of BMS-936561 (MDX-1203), an antibody-drug conjugate targeting CD70.
Academic Article	Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial.
Academic Article	Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.
Academic Article	Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.
Academic Article	Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma.
Academic Article	Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma.
Academic Article	Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma.
Academic Article	Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer.
Academic Article	Prognostic importance of lymphovascular invasion in urothelial carcinoma of the renal pelvis.
Academic Article	Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Academic Article	Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy.
Academic Article	The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?
Academic Article	Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial.
Academic Article	Patient-Reported Outcomes from the Phase III Randomized IMmotion151 Trial: Atezolizumab + Bevacizumab versus Sunitinib in Treatment-Naïve Metastatic Renal Cell Carcinoma.
Academic Article	Eosinophilic renal cell carcinoma with isolated MTOR mutation metastatic to the liver: a novel case.
Academic Article	Angiokines Associated with Targeted Therapy Outcomes in Patients with Non-Clear Cell Renal Cell Carcinoma.
Academic Article	Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial.
Academic Article	Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC).
Academic Article	A Prospective Multicenter Evaluation of Initial Treatment Choice in Metastatic Renal Cell Carcinoma Prior to the Immunotherapy Era: The MaRCC Registry Experience.
Academic Article	Tissue based biomarkers in non-clear cell RCC: Correlative analysis from the ASPEN clinical trial.
Academic Article	NF2-mutated Renal Carcinomas Have Common Morphologic Features Which Overlap With Biphasic Hyalinizing Psammomatous Renal Cell Carcinoma: A Comprehensive Study of 14 Cases.
Academic Article	Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma.
Academic Article	Emerging targets in kidney cancer: opportunities for drug development.
Academic Article	Evaluation of Provider Preferences in First-Line Metastatic Renal Cell Carcinoma: Comparison Between Dual Immunotherapy vs. Immunotherapy/Tyrosine Kinase Inhibitors.

Search Criteria

Renal Cancer